CANAKINUMAB TREATMENT IN PATIENTS WITH COLCHICINE-RESISTANT FMF (CRFMF), HIDS/MKD AND TRAPS: EFFICACY IN THE 16 WEEKS RANDOMISED CONTROLLED PHASE AND MAINTENANCE OF DISEASE CONTROL AND SAFETY AT WEEK 40

Ozen, S.; De Benedetti, F.; Gattorno, M.; Frenkel, J.; Calvo, I.; Moutschen, M.; Quartier, P.; Anton, J.; Kone-Paut, I.; Lachmann, H.; Hoffman, H. M.; Ben-Chetrit, E.; Zeft, A.; Gong, Y.; Vritzali, E.; Junge, G.; Gul, A.; Kasapcopur, O.

dc.contributor.author	Ozen, S.
dc.contributor.author	De Benedetti, F.
dc.contributor.author	Gattorno, M.
dc.contributor.author	Frenkel, J.
dc.contributor.author	Calvo, I.
dc.contributor.author	Moutschen, M.
dc.contributor.author	Quartier, P.
dc.contributor.author	Anton, J.
dc.contributor.author	Kone-Paut, I.
dc.contributor.author	Lachmann, H.
dc.contributor.author	Hoffman, H. M.
dc.contributor.author	Ben-Chetrit, E.
dc.contributor.author	Zeft, A.
dc.contributor.author	Gong, Y.
dc.contributor.author	Vritzali, E.
dc.contributor.author	Junge, G.
dc.contributor.author	Gul, A.
dc.contributor.author	Kasapcopur, O.
dc.date.accessioned	2021-03-03T13:21:30Z
dc.date.available	2021-03-03T13:21:30Z
dc.identifier.citation	De Benedetti F., Gattorno M., Frenkel J., Calvo I., Moutschen M., Quartier P., Kasapcopur O., Ozen S., Gul A., Anton J., et al., "CANAKINUMAB TREATMENT IN PATIENTS WITH COLCHICINE-RESISTANT FMF (CRFMF), HIDS/MKD AND TRAPS: EFFICACY IN THE 16 WEEKS RANDOMISED CONTROLLED PHASE AND MAINTENANCE OF DISEASE CONTROL AND SAFETY AT WEEK 40", Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.77
dc.identifier.other	vv_1032021
dc.identifier.other	av_338afdde-4dc9-47c5-bbae-557f672b955d
dc.identifier.uri	http://hdl.handle.net/20.500.12627/38902
dc.identifier.uri	https://doi.org/10.1136/annrheumdis-2017-eular.2194
dc.language.iso	eng
dc.subject	ROMATOLOJİ
dc.subject	Klinik Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	İmmünoloji ve Romatoloji
dc.title	CANAKINUMAB TREATMENT IN PATIENTS WITH COLCHICINE-RESISTANT FMF (CRFMF), HIDS/MKD AND TRAPS: EFFICACY IN THE 16 WEEKS RANDOMISED CONTROLLED PHASE AND MAINTENANCE OF DISEASE CONTROL AND SAFETY AT WEEK 40
dc.type	Bildiri
dc.contributor.department	IRCCS Bambino Gesu , ,
dc.identifier.volume	76
dc.contributor.firstauthorID	151732

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Bildiri [64839]

Basit öğe kaydını göster